Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Cancer immunotherapy can induce durable antitumor responses. However, many patients poorly respond to such therapies. Here we describe a generic antitumor therapy that is based on the intratumor delivery of mRNA that codes for the necroptosis executioner mixed lineage kinase domain-like (MLKL) prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Hoecke, Lien, Van Lint, Sandra, Roose, Kenny, Van Parys, Alexander, Vandenabeele, Peter, Grooten, Johan, Tavernier, Jan, De Koker, Stefaan, Saelens, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109072/
https://www.ncbi.nlm.nih.gov/pubmed/30143632
http://dx.doi.org/10.1038/s41467-018-05979-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109072/
https://www.ncbi.nlm.nih.gov/pubmed/30143632
http://dx.doi.org/10.1038/s41467-018-05979-8

Ejemplares similares